DILIC
ELV icon

Dai-ichi Life Insurance Company’s Elevance Health ELV Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.2M Buy
10,863
+1,450
+15% +$538K 0.1% 187
2026
Q1 		$2.76M Sell
9,413
-272
-3% -$89.4K 0.08% 210
2025
Q4 		$3.4M Hold
9,685
– – 0.09% 203
2025
Q3 		$3.13M Sell
9,685
-1,591
-14% -$495K 0.08% 212
2025
Q2 		$4.39M Sell
11,276
-11,857
-51% -$4.77M 0.12% 165
2025
Q1 		$10.1M Buy
23,133
+7,300
+46% +$2.93M 0.29% 84
2024
Q4 		$5.84M Sell
15,833
-3,707
-19% -$1.55M 0.16% 143
2024
Q3 		$10.2M Sell
19,540
-2,545
-12% -$1.36M 0.26% 93
2024
Q2 		$12M Sell
22,085
-779
-3% -$412K 0.29% 87
2024
Q1 		$11.9M Sell
22,864
-2,296
-9% -$1.14M 0.27% 89
2023
Q4 		$11.9M Sell
25,160
-142
-0.6% -$65.7K 0.25% 92
2023
Q3 		$11M Buy
25,302
+4,000
+19% +$1.81M 0.24% 88
2023
Q2 		$9.46M Buy
21,302
+4,000
+23% +$1.85M 0.2% 102
2023
Q1 		$7.96M Sell
17,302
-5,264
-23% -$2.51M 0.17% 113
2022
Q4 		$11.6M Buy
22,566
+7,726
+52% +$3.92M 0.27% 76
2022
Q3 		$6.74M Hold
14,840
– – 0.17% 117
2022
Q2 		$7.16M Sell
14,840
-6,000
-29% -$2.97M 0.16% 127
2022
Q1 		$10.2M Buy
20,840
+1,637
+9% +$748K 0.16% 123
2021
Q4 		$8.9M Sell
19,203
-2,173
-10% -$914K 0.11% 156
2021
Q3 		$7.97M Sell
21,376
-386
-2% -$147K 0.1% 158
2021
Q2 		$8.31M Sell
21,762
-153
-0.7% -$58.5K 0.1% 169
2021
Q1 		$7.87M Hold
21,915
– – 0.11% 158
2020
Q4 		$7.04M Buy
21,915
+4,095
+23% +$1.26M 0.1% 163
2020
Q3 		$4.79M Sell
17,820
-11,218
-39% -$3.02M 0.09% 174
2020
Q2 		$7.64M Buy
29,038
+5,456
+23% +$1.46M 0.17% 103
2020
Q1 		$5.35M Buy
23,582
+4,216
+22% +$1.15M 0.21% 114
2019
Q4 		$5.85M Sell
19,366
-5,251
-21% -$1.45M 0.13% 173
2019
Q3 		$5.91M Buy
24,617
+5,396
+28% +$1.48M 0.14% 161
2019
Q2 		$5.42M Buy
19,221
+28
+0.1% +$7.65K 0.13% 171
2019
Q1 		$5.51M Buy
19,193
+60
+0.3% +$17.4K 0.14% 165
2018
Q4 		$5.03M Sell
19,133
-223
-1% -$61.3K 0.14% 175
2018
Q3 		$5.3M Hold
19,356
– – 0.11% 183
2018
Q2 		$4.61M Sell
19,356
-2,300
-11% -$533K 0.11% 194
2018
Q1 		$4.76M Hold
21,656
– – 0.1% 198
2017
Q4 		$4.87M Sell
21,656
-465
-2% -$99K 0.09% 192
2017
Q3 		$4.2M Sell
22,121
-5,890
-21% -$1.12M 0.09% 213
2017
Q2 		$5.27M Buy
28,011
+14,931
+114% +$2.68M 0.12% 180
2017
Q1 		$2.16M Hold
13,080
– – 0.06% 291
2016
Q4 		$1.88M Buy
+13,080
New +$1.75M 0.06% 309

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dai-ichi Life Insurance Company's ELV Position: Q2 2026 in Review

Dai-ichi Life Insurance Company increased its Elevance Health (ELV) stake by 15% in Q2 2026, buying an estimated $538K and bringing the position to 10,863 shares worth $4.2M. The position accounts for 0.1% of the portfolio, ranked #187.

Dai-ichi Life Insurance Company first reported a position in ELV in Q4 2016 and has held it in 39 quarters since. The position peaked at $12M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Dai-ichi Life Insurance Company held 10,863 shares of Elevance Health worth $4.2M as of Q2 2026.
  • Dai-ichi Life Insurance Company bought 1,450 Elevance Health shares in Q2 2026, an estimated $538K.
  • Elevance Health made up 0.1% of Dai-ichi Life Insurance Company's portfolio in Q2 2026, its #187 holding.
  • Dai-ichi Life Insurance Company first reported a position in Elevance Health in Q4 2016 and has held it in 39 quarters since.
  • Dai-ichi Life Insurance Company's Elevance Health position peaked at $12M in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Dai-ichi Life Insurance Company's 13F filing for Q2 2026, filed 12 Aug 2026.